Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
GSTA1 Drives Oxidative Stress in α-Amanitin Injury
2026-09-22
The reference study identifies GSTA1 as an unexpected driver of α-amanitin hepatotoxicity: instead of protecting hepatocytes, its upregulation accelerates glutathione depletion and reactive oxygen species accumulation. By integrating mouse pathology, multi-omics, target-interaction assays, and genetic knockdown, the work positions GSTA1 as a mechanistically actionable target in amatoxin-induced liver injury.
AG-120 (Ivosidenib) Assay Guide
2026-09-22
A practical, scenario-based guide to using AG-120 (Ivosidenib), mutant IDH1 inhibitor (SKU B7805) in viability, proliferation, differentiation, and 2-hydroxyglutarate assays. It connects mutant IDH1 biology with solvent handling, orthogonal readouts, interpretation, and evidence-based product selection.
Phosbind Biotin LC: PVDF Detection Guide
2026-09-21
Phosbind Biotin LC is a phosphate-binding reagent for detecting phosphorylated proteins on PVDF membranes without relying on a phospho-specific antibody or a particular sequence context. It is intended primarily for Western Blot workflows and should not be used in aqueous-only protocols or for long-term storage of prepared solutions.
Parathyroid hormone (1-34) (human) in Kidney Models
2026-09-21
Use the PTH (1-34) peptide fragment to connect receptor-level cAMP assays with spatially organized kidney assembloids and bone metabolism research. This workflow combines dose-resolved signaling, compartment-aware readouts, and practical handling guidance for calcium homeostasis and osteoporosis model studies.
GS-441524 Workflow for Prodrug Conversion Studies
2026-09-20
Build a conversion-focused workflow around GS-441524 for antiviral assay development, LC–MS/MS method setup, and pharmacokinetic interpretation. The approach separates parent compound, prodrug, and converted metabolite signals so that apparent exposure is not confused with bioactivation or antiviral effect.
PtrbZIP12 Controls Poplar Drought Resistance
2026-09-19
The reference study identifies PtrbZIP12 as a positive regulator of drought resistance in Populus trichocarpa and connects its activity to direct activation of PtrDHN and PtrPOD. By combining transgenic genetics, transcriptomics, promoter-binding assays, and phosphorylation analysis, the work links transcription-factor regulation with antioxidant defense, osmotic adjustment, and stress-responsive signaling.
Preserving Phosphosignals in TERT Research
2026-09-18
A mechanistic and translational framework for preserving phosphorylation states while investigating APEX2-dependent TERT expression, telomerase biology, and DNA-repair signaling. The article explains how a dual-component phosphatase inhibition strategy can strengthen experimental interpretation without overstating what the current evidence proves.
Phosbind Biotin for Protein Phosphorylation Analysis
2026-09-18
Phosbind Biotin enables sequence-independent Western Blot detection of phosphorylated proteins, offering a practical alternative when phospho-specific antibodies are unavailable or too narrowly targeted. Its dinuclear metal complex phosphate binding supports pathway studies such as the phosphorylation-dependent drought response reported for PtrbZIP12 in poplar.
Nicotinamide Riboside Chloride in iPSC-RGC Models
2026-09-17
Nicotinamide Riboside Chloride (NIAGEN) can be evaluated as a metabolic-state variable alongside chemically defined iPSC-to-RGC differentiation. This article translates the reference study into practical assay decisions while distinguishing lineage induction from NAD+-linked cellular resilience.
SmCPK20–SmWRKY2 Control of Tanshinone Synthesis
2026-09-17
The 2026 study identifies a post-translational mechanism linking jasmonate perception, calcium-dependent protein kinase activity, and tanshinone biosynthesis in Salvia miltiorrhiza. Its central finding is that SmCPK20 phosphorylates SmWRKY2 at Thr-256, strengthening SmCPS1 promoter activation after jasmonate-triggered release from SmJAZ3 repression.
Zolmitriptan 5-HT1B Research Workflows
2026-09-16
Build reproducible Zolmitriptan assays around receptor subtype selectivity, solvent control, and time-resolved neurovascular readouts. This guide separates evidence-based migraine and cluster headache applications from lysosomal biology insights that can improve assay design without implying an antiviral role.
RRP Restores Lipid Metabolism in Hepatic IRI
2026-09-16
A 2024 Journal of Ethnopharmacology study shows that Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury by rebalancing hepatocyte cholesterol metabolism. Its mechanistic model links AMPK activation to suppression of SCAP-SREBP2 cholesterol synthesis and enhancement of LXRα-dependent cholesterol efflux, providing a useful framework for lipid-injury research.
Phosbind Acrylamide: SDS-PAGE Guide
2026-09-15
Phosbind Acrylamide is a phosphate-binding reagent for comparing phosphorylated and non-phosphorylated proteins through phosphorylation-dependent mobility shifts during SDS-PAGE. It is suited to protein phosphorylation analysis, particularly for targets in the 30–130 kDa range, but it should not be treated as a phosphosite-identification method or a substitute for quantitative phosphorylation assays.
Tomivosertib: Mapping MNK–eIF4E in Glioblastoma
2026-09-15
Tomivosertib is a potent MNK1 inhibitor for dissecting translational control in glioblastoma. This article focuses on compartment-resolved target engagement, angiogenesis assays, and chemotherapy-response mechanisms rather than repeating general MNK biology.
GS-441524: Mechanism, Evidence & Workflow
2026-09-14
GS-441524 is a nucleoside analog studied as an anti-SARS-CoV-2 nucleoside analog and intracellular precursor to an active triphosphate. Current GS-441524 antiviral research distinguishes the parent nucleoside from engineered prodrugs such as NGP-1 and uses LC–MS/MS to resolve conversion, exposure, and matrix effects.